Provided by Tiger Fintech (Singapore) Pte. Ltd.

Greenfire Resources Ltd

4.67
+0.01000.21%
Volume:97.01K
Turnover:454.20K
Market Cap:326.54M
PE:3.95
High:4.85
Open:4.61
Low:4.54
Close:4.66
Loading ...

Greenfire Resources Full Year 2024 Earnings: EPS: CA$1.76 (vs CA$2.49 loss in FY 2023)

Simply Wall St.
·
19 Mar

Greenfire Resources Q4 2024 GAAP EPS C$1.09 Up From C$(0.07) YoY

Benzinga
·
18 Mar

Greenfire Resources Reports Year End 2024 Reserves, Fourth Quarter and Full Year 2024 Results, and Provides an Operational Update

Newsfile
·
18 Mar

Greenfire Resources Ltd.'s (NYSE:GFR) largest shareholders are private equity firms with 56% ownership, institutions own 19%

Simply Wall St.
·
14 Mar

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
10 Mar

Greenfire Resources Ltd. (NYSE:GFR) Might Not Be As Mispriced As It Looks

Simply Wall St.
·
08 Mar

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

GlobeNewswire
·
04 Mar

MediBeacon® Transdermal GFR System receives device approval in China

GlobeNewswire
·
25 Feb

Huadong Medicine's Unit Secures Approval for Filtration Measurement Device

MT Newswires Live
·
20 Feb

Greenfire Resources Announces New President and Departure of Senior Executives

Newsfile
·
12 Feb

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

GlobeNewswire
·
07 Feb

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

GlobeNewswire
·
18 Jan

Greenfire Resources Initiates Offer for Secured Notes

TIPRANKS
·
28 Dec 2024

Greenfire Resources Announces Change of Control Offer to Purchase 12.000% Senior Secured Notes due 2028

Newsfile
·
28 Dec 2024

Dow Jumps Over 200 Points, Crude Oil Gains 1.5%

Benzinga
·
25 Dec 2024

Greenfire Resources Restructures Board Amid Strategic Changes

TIPRANKS
·
24 Dec 2024

Greenfire Resources Announces Reconstitution of the Company's Board of Directors, Acquisition of Additional Greenfire Securities by WEF and Continuation of the Strategic Review

Newsfile
·
24 Dec 2024

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

GlobeNewswire
·
20 Dec 2024

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

GlobeNewswire
·
19 Dec 2024

Greenfire Resources Strengthens Board and Schedules Shareholder Meeting

TIPRANKS
·
09 Dec 2024